[Experiences with bromocriptine treatment of female infertility due to hyperprolactinemia].

Abstract

From July 1981 to September 1988, 106 infertile patients with hyperprolactinemia treated with bromocriptine were reviewed retrospectively with special attention to the dosage of bromocriptine and the evaluation of infertility before treatment 84 patients (79.2%) became pregnant. The patients were divided into 3 groups according to the following doses of bromocriptine: 7.5, 5.0, and less than 5.0 mg/day. The pregnancy rate was 90.7%, 84.6%, and 66.7% respectively with the highest at 7.5mg/day, which was significantly higher than that at less than 5.0mg/day (P less than 0.02). The average duration from treatment to pregnancy was 3.6, 3.4, and 7.4 months respectively. The duration in the less than 5mg/day group was twice that in the other two groups. 84.5% of the pregnancies occurred within 6 months of treatment. Pretreatment of organic lesions and additional therapy for induction of ovulation were given to 29.8% of patients who later became pregnant. Systematic evaluation of the causes of infertility other than hyperprolactinemia before the use of bromocriptine and an optimal dose of 5-7.5mg/day will give the best results.

• Authors: S Q Lin
• Journal: Zhonghua fu chan ke za zhi (Zhonghua Fu Chan Ke Za Zhi) Vol. 27 Issue 1 Pg. 28-31, 59 (Jan 1992) ISSN: 0529-567X [Print] China
• PMID: 1505275 (Publication Type: English Abstract, Journal Article)

Chemical References

• Bromocriptine

Topics

• Adult
• Bromocriptine (administration & dosage, therapeutic use)
• Female
• Humans
• Hyperprolactinemia (complications)
• Infertility, Female (drug therapy, etiology)
• Pituitary Neoplasms (complications)
• Prolactinoma (complications)
• Retrospective Studies